2013 annual financial data
Dyne Therapeutics 2013 Net margin
Dyne Therapeutics 2013 net margin with verified reported values.
Direct answer
Net margin was -11,866.67%.
Operating income was -318,000,000 USD and net income was -356,000,000 USD.
Operating cash flow was 175,000,000 USD.
Get free Dyne Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,000,000 USD
- Operating income
- -318,000,000 USD
- Net income
- -356,000,000 USD
- Operating cash flow
- 175,000,000 USD